The science of molecular cell biology has advanced dramatically over the last century and in the last decade this has had important implications for medical research particularly for oncology, microbiology, immunology, and inherited genetic diseases. Globally, the oncological sciences fig 8A. The sequencing gel indicates a single base pair transition of E-cadherin gene resulting in a change from leucine to proline.
Summary and future prospects These techniques can be used to aid diagnosis, prognosis and therapy in many aspects of clinical medicine. It is perhaps in the area oftumour biology where the applications are greatest. In particular the identification of c-ras mutations in codon 12 has already been used as a potential screening aid for colorectal cancer when applied to faecal cytology.6 Furthermore, identification of mutations in the p53 and c-ras genes has also been shown to have prognostic significance in addition to tumour size, stage and morphology.7 At present, only 5% of the human genome is characterised and therefore identification of novel genes which have a role in normal development and tumorigenesis is urgently required. In this regard simple techniques such as DOP PCR enable such strategies to be achieved. This technique has been used successfully to identify HEX, a novel homeodomain gene expressed during haematopoiesis.' This strategy has also been employed to identify E-cadherin homologues, which have an important role in colorectal cancer.
As suggested in the introduction gene transfer therapy has already been performed in several clinical areas, most notably in the treatment of inherited enzyme deficiencies. As yet, its application in cancer is still experimental but several strategies are possible such as enhancing immune surveillance and antibody targeting.9
Finally, this short leader has several key references which may be of use to those wishing to undertake any of the procedures outlined above. 
